Omega-3 long chain polyunsaturated fatty acids to prevent preterm birth : A systematic review and meta-analysis

Obstetrics and Gynecology

Volumn 125, Issue 3, 2015, Pages 663-672

  Saccone, Gabriele ^a,b   Berghella, Vincenzo ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEHYDROACETIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID;

BIRTH WEIGHT; COCHRANE LIBRARY; CONFIDENCE INTERVAL; HUMAN; MEDLINE; META ANALYSIS; NECROTIZING ENTEROCOLITIS; NEWBORN INTENSIVE CARE; PERINATAL DEATH; PREGNANCY; PREMATURE LABOR; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SCOPUS; SEPSIS; SYSTEMATIC REVIEW; DIET SUPPLEMENTATION; FEMALE; PREMATURE BIRTH;

DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; PREGNANCY; PREMATURE BIRTH;

EID: 84923583459     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/AOG.0000000000000668     Document Type: Review

References (42)

1. Olsen SF, Hansen HS, Sørensen TI, Jensen B, Secher NK, Sommer S, et al. Intake of marine fat, rich in (n-3)-polyunsaturated fatty acids may increase birthweight by prolonging gestation. Lancet 1986;2:367-9.
2. Hamilton BE, Martin JA, Ventura SJ. Births: preliminary data for 2011. Natl Vital Stat Rep 2012;61:1-18.
3. Spong CY. Prediction and prevention of recurrent spontaneous preterm birth. Obstet Gynecol 2007;110:405-15.
4. Olsen SF, Sørensen JD, Secher NJ, Hedegaard M, Henriksen TB, Hansen HS, et al. Randomized controlled trial of effect of fish oil supplementation on pregnancy duration. Lancet 1992;339:1003-7.
5. Bulstra-Ramakers MT, Huisjes HJ, Visser GH. The effects of 3g eicosapentaenoic acid daily on recurrence of intrauterine growth retardation and pregnancy induced hypertension. Br J Obstet Gynaecol 1994;102:123-6.
6. Onwude JL, Lilford RJ, Hjartardottir H, Staines A, Tuffnell D. A randomized double blind placebo controlled trial of fish oil in high risk pregnancy. Br J Obstet Gynaecol 1995;102:95-100.
7. Malcolm CA, Hamilton R, McCulloch DL, Montgomery C, Weaver LT. Scotopic electroretinogram in term infants born of mothers supplemented with docosahexaenoic acid during pregnancy. Invest Ophthalmol Vis Sci 2003;44:3685-91.
8. Sanjuro P, Ruiz-Sanz JI, Jimeno P, Aldámiz-Echevarría L, Aquino L, Matorras R, et al. Supplementation with docosahexaenoic acid in the last trimester of pregnancy: maternal-fetal biochemical findings. J Perinat Med 2004;32:132-6.
9. Decsi T, Campoy C, Koletzko B. Effect of N-3 polyunsaturated fatty acid supplementation in pregnancy: the Nuheal trial. Adv Exp Med Biol 2005;569:109-13.
10. Tofail F, Kabir I, Hamadani JD, Chowdhury F, Yesmin S, Mehreen F, et al. Supplementation of fish-oil and soy-oil during pregnancy and psychomotor development of infants. J Health Popul Nutr 2006;24:48-56.
11. Makrides M, Gibson RA, McPhee AJ, Yelland L, Quinlivan J, Ryan P, et al. Effect of DHA supplementation during pregnancy on maternal depression and neurodevelopment of young children: a randomized controlled trial. JAMA 2010; 304:1675-83.
12. Escolano-Margarit MV, Ramos R, Beyer J, Csabi G, Parrilla-Roure M, Cruz F, et al. Prenatal DHA status and neurological outcome in children at age 5.5 years are positively associated. J Nutr 2011;141:1216-23.
13. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. J Clin Epidemiol 2009;62: 1006-12.
14. Higgins JPT, Altman DG, Sterne JAC. Assessing risk of bias in included studies. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions, version 5.10 (update 2011). The Cochrane Collaboration; 2011. Available at: http://www.cochrane-handbook.org. Retrieved August 15, 2014.
15. Colombo J, Kannass KN, Shaddy DJ, Kundurthi S, Maikranz JM, Anderson CJ, et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev 2004;75:1254-67.
16. Boris J, Jensen B, Salving JD, Secher NK, Olsen SF. A randomized controlled trial of the effect of fish oil supplementation in late pregnancy and early lactation on the n-3 fatty acid content in human breast milk. Lipids 2004;39:1191-6.
17. Borod E, Atkinson R, Barclay WR, Carlson SE. Effects of third trimester consumption of eggs high in docosahexaenoic acid on docosahexaenoic acid status and pregnancy. Lipids 1999;34 (suppl):S231.
18. van Houwelingen AC, Sørensen JD, Hornstra G, Simonis MM, Boris J, Olsen SF, et al. Essential fatty acid status in neonates after fish oil supplementation during late pregnancy. Br J Nutr 1995;74:723-31.
19. Montgomery C, Speake BK, Cameron A, Sattar N, Weaver LT. Maternal docosahexaenoic acid supplementation and fetal accretion Br J Nutr 2003;90:135-45.
20. Salving JD, Olsen SF, Secher NJ. Effect of fish oil supplementation in late pregnancy on blood pressure: a randomized controlled trial. Br J Obstet Gynaecol 1996;103:529-33.
21. Smuts CM, Huang M, Mundy D, Plasse T, Major S, Carlson SE. A randomized trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol 2003;101:469-79.
22. Olsen SF, Secher NJ, Tabor A, Weber T, Walker JJ, Gluud C. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP). BJOG 2000;107:382-95.
23. Harper M, Thom E, Klebanoff MA, Thorp J Jr, Sorokin Y, Varmer MW, et al. Omega-3 fatty acid supplementation to prevent recurrent preterm birth: a randomized controlled trial. Obstet Gynecol 2010;115:234-42.
24. D'Almeida A, Carter JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docosahexaenoic acid) versus magnesium, and versus placebo in preventing preeclampsia. Women Health 1992;19:117-31.
25. De Groot RH, Hornstra G, van Houwelingen AC, Roumen F. Effect of alpha-linolenic acid supplementation during pregnancy on maternal and neonatal polyunsaturated fatty acid status and pregnancy outcome. Am J Clin Nutr 2004;79: 251-60.
26. Herrera JA, Arevalo-Herrera M, Herrera S. Prevention of preeclampsia by linoleic acid and calcium supplementation: a randomized controlled trial. Obstet Gynecol 1998;91:585-90.
27. Colombo J, Carlson SE, Cheatham CL, Shaddy DJ, Kerling EH, Thodosoff JM, et al. Long-term effects of LCPUFA supplementation on childhood cognitive outcomes. Am J Clin Nutr 2013;98:403-12.
28. Olsen SF, Secher NJ. A possible preventive effect of low-dose fish oil on early delivery and pre-eclampsia: indication from a 50-year-old controlled trial. Br J Nutr 1990;64:599-609.
29. Laivuori H, Hovatta O, Viinikka L, Ylikorkala O. Dietary supplementation with primrose oil or fish oil dose not change urinary excretion of prostacyclin and thromboxane metabolites in pre-eclamptic women. Prostaglandins Leukot Essent Fatty Acids 1993;49:691-4.
30. Helland IB, Saugstad OD, Smith L, Saarem K, Solvoll K, Ganes T, et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics 2001;108:E82.
31. Knudsen VK, Hansen HS, Osterdal ML, MIkkelsen TB, Mu H, Olsen SF. Fish oil in various doses or flax oil in pregnancy and timing of spontaneous delivery: a randomized controlled trial. BJOG 2006;113:536-43.
32. Gould JF, Makrides M, Colombo J, Smithers LG. Randomized controlled trial of maternal omega-3 long-chain PUFA supplementation during pregnancy and early childhood development of attention, working memory, and inhibitory control. Am J Clin Nutr 2014;99:851-9.
33. Mulder KA, King DJ, Innis SM. Omega-3 fatty acid deficiency in infants before birth identified using a randomized trial of maternal DHA supplementation in pregnancy. PLoS One 2014;9:e83764.
34. Smuts CM, Borod E, Peeples JM, Carlson SE. High-DHA eggs: feasibility as a means to enhance circulating DHA in mother and infant. Lipids 2003;38:407-14.
35. Szajewska H, Horvath A, Koletzko B. Effect of n-3 long-chain polyunsaturated fatty acid supplementation of women with lowrisk pregnancies on pregnancy outcome and growth measures at birth: a meta-Analysis of randomized controlled trials. Am J Clin Nutr 2006;83:1337-44.
36. Horvath A, Koletzko B, Szajewska H. Effect of supplementation of women in high-risk pregnancies with long-chain polyunsaturated fatty acids on pregnancy outcomes and growth measures at birth: a meta-Analysis of randomized controlled trials. Br J Nutr 2007;98:253-9.
37. Salvig JD, Lamont RF. Evidence regarding an effect of marine n-3 fatty acids on preterm birth: a systematic review and metaanalysis. Acta Obstet Gynecol Scand 2011;90:825-38.
38. Makrides M, Duley L, Olsen SF. Marine oil, and other prostaglandin precursor, supplementation for pregnancy uncomplicated by pre-eclampsia or intrauterine growth restriction. The Cochrane Database of Systematic Reviews 2006, Issue 3. Art. No.: CD003402. DOI: 10.1002/14651858.CD003402.pub2.
39. Society for Maternal-Fetal Medicine Publications Committee, with assistance of Vincenzo Berghella. Progesterone and preterm birth prevention: translating clinical trials data into clinical practice. Am J Obstet Gynecol 2012;206:376-86.
40. Berghella V, Odibo AO, To MS, Rust OA, Althuisius SM. Cerclage for short cervix on ultrasonography: a meta-Analysis of trials using individual patient-level data. Obstet Gynecol 2005;106:181-9.
41. Food and Agriculture Organization of the United Nations. Fats and fatty acids in human nutrition; report of an expert consultation. 2008. Available at: http://www.fao.org/docrep/013/i1953e/i1953e00.pdf. Retrieved August 15, 2014.
42. World Health Organization. Marine oil supplementation to improve pregnancy outcomes. Geneva (Switzerland): WHO; 2011. Available at: http://www.who.int/elena/titles/bbc/fish- oil-pregnancy/en/. Retrieved August 15, 2014.